These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 40676)

  • 41. Effect of drugs influencing synthesis of prostaglandins on haloperidol-induced catalepsy in rats.
    Bala Lall S; Tekur U; Sen P
    Indian J Physiol Pharmacol; 1984; 28(3):219-22. PubMed ID: 6440863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice].
    Shapovalova VO; Mykhaĭlov VS; Shapovalov VV
    Fiziol Zh (1994); 1999; 45(3):114-7. PubMed ID: 10439301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nonuniform effect of cataleptogenic and atypical neuroleptics on the turning reactions induced by stimulation of the putamen and caudate nucleus in cats].
    Anokhov SS; Arushanian EB
    Farmakol Toksikol; 1984; 47(6):16-20. PubMed ID: 6151517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Differentiating the action of cataleptogenic bodies (author's transl)].
    Menge HG; Brand U
    Arzneimittelforschung; 1978; 28(9):1506-7. PubMed ID: 38810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cataleptogenic potency of the antipsychotic drugs is inversely correlated with neuronal activity in the amygdaloid complex of the rat.
    Rebec GV; Gelman J; Alloway KD; Bashore TR
    Pharmacol Biochem Behav; 1983 Nov; 19(5):759-63. PubMed ID: 6139828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.
    Elliott PJ; Close SP; Walsh DM; Hayes AG; Marriott AS
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):79-89. PubMed ID: 1977409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individual phenotype predicts nicotine-haloperidol interaction in catalepsy: possible implication for the therapeutic efficacy of nicotine in Tourette's syndrome.
    Boye SM
    Behav Brain Res; 2013 Jan; 236(1):30-34. PubMed ID: 22947904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute lithium administration selectively lowers tyrosine levels in serum and brain.
    McFarlane HG; Steele J; Vinion K; Bongiovanni R; Double M; Jaskiw GE
    Brain Res; 2011 Oct; 1420():29-36. PubMed ID: 21962398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
    Yamada K; Furukawa T
    Pharmacology; 1982; 24(3):147-55. PubMed ID: 7200248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of haloperidol-induced catalepsy by ascorbic acid in rats and nonhuman primates.
    Dorris RL; Dill RE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):781-3. PubMed ID: 3703914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of haloperidol-induced catalepsy by cholecystokinin octapeptides after central administration to rats.
    Kádár T; Penke B; Kovács K; Telegdy G
    Neuropharmacology; 1985 Jun; 24(6):577-80. PubMed ID: 2862602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentiation of haloperidol catalepsy by microinjections of nicotine into the striatum or pons in rats.
    Elazar Z; Paz M
    Life Sci; 1999; 64(13):1117-25. PubMed ID: 10210274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Further studies on the neuroleptic profile of manassantin A.
    Rao KV; Puri VN; el-Sawaf HA
    Eur J Pharmacol; 1990 Apr; 179(3):367-76. PubMed ID: 1973109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs.
    McMillen BA; Scott SM; Davanzo EA
    J Pharm Pharmacol; 1988 Dec; 40(12):885-7. PubMed ID: 2907585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of GABA-agonists and antagonists on neuroleptic-induced catalepsy in rats.
    Worms P; Lloyd KG
    Life Sci; 1978 Aug; 23(5):475-7. PubMed ID: 29189
    [No Abstract]   [Full Text] [Related]  

  • 56. The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics.
    Fuenmayor LD; Vogt M
    Br J Pharmacol; 1979 Oct; 67(2):309-18. PubMed ID: 40649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The neuroleptic substances and the behavior of insects. III. Influence on the post-embryonic development of Tribolium confusum Duval (Coleoptera: Tenebrionidae)].
    HUOT L; CORRIVAULT GW; LEBLANC J
    Arch Int Physiol Biochim; 1963 Mar; 71():215-23. PubMed ID: 13955808
    [No Abstract]   [Full Text] [Related]  

  • 58. Disulfiram and the effect of catecholamines on neuroleptic-induced catalepsy in mice and rats.
    Maj J; Przegaliński E
    J Pharm Pharmacol; 1967 Jan; 19(1):68-9. PubMed ID: 4382185
    [No Abstract]   [Full Text] [Related]  

  • 59. Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy.
    Maj J; Mogilnicka E; Przewlocka B
    Pharmacol Biochem Behav; 1975; 3(1):25-7. PubMed ID: 1168927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antagonism between dopaminergic and neuroleptic drugs. I. Acute administration.
    Bo P; Savoldi F; Tartara A
    Farmaco Sci; 1979 Jul; 34(7):621-7. PubMed ID: 38998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.